Bivalirudin (Hospira, Inc.)
Welcome to the PulseAid listing for the Bivalirudin drug offered from Hospira, Inc.. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | BIVALIRUDIN |
SUBSTANCE NAME: | BIVALIRUDIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-07-30 |
END MARKETING DATE: | 0000-00-00 |
Bivalirudin HUMAN PRESCRIPTION DRUG Details:
Item Description | Bivalirudin from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2015-07-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-8300_264eb68f-64f7-4d47-b158-c1544f3bbe29 |
PRODUCT NDC: | 0409-8300 |
APPLICATION NUMBER: | ANDA090811 |
Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers: